However, while u-NGAL was higher in LN compared to ANR-SLE patients (p = .008) and INR-SLE (p < .0001), this urine biomarker showed similar levels in LN patients and PBC (p = .08). This evidence concerns the gene LCN2 and systemic lupus erythematosus.